Tag Archive | "Baxter"

Rockwell forms a biotech partnership with Baxter for $45 million

Tags: , , , ,


Baxter International gave kidney drug developer Rockwell Medical a big boost in the form of $45 million in graduated payments in a biotech partnership. Read the full story

Baxter and Merrimack ink a pharma licensing deal for developing cancer drug

Tags: , , ,


Baxter International had entered into an exclusive pharma licensing and collaboration agreement with Merrimack Pharmaceuticals to develop and commercialize lead cancer drug MM-398. Read the full story

Big pharma, Baxter sells its vaccines for $635 million

Tags: , , , ,


Big pharma, Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer for a total cash consideration of $635 million, subject to certain adjustments. Read the full story

M&A news: Baxter has acquired AesRX

Tags: , , ,


In today’s m&a news, Baxter International announced the acquisition of AesRx. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term ‘top pharma’ can relate to the top pharmaceutical companies or the top 10 or 50… Read the full story

Baxter

Tags: ,


Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA Read the full story

Merger & acquisition between Baxter and Chatham Therapeutics

Tags: , , , , ,


Baxter International has agreed for merger & acquisition for Chatham Therapeutics for $70 million. Read the full story

Big Pharma, Baxter International, plans to split itself in two

Tags: , , , ,


Big Pharma, Baxter International announced plans to create two separate, independent global healthcare companies — one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Read the full story

Baxter enters into a biotech deal for hemophilia

Tags: , , ,


Baxter International has restructured its ongoing biotech deal with Xenetic Bioscience for the development of BAX 826 to assess its potential to extend the half-life and duration of effectiveness.

Read the full story

Baxter enters into a pharma licencing deal for $172 million

Tags: , , , ,


Baxter International and Cell Therapeutics have entered into an exclusive worldwide pharma licensing deal to develop and commercialize pacritinib for $172 million. Read the full story

cpbannerad300x150new1gif
e56300x150animgif
current-partnering-300x150-orphanjpg
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new3gif
e56300x150animgif
current-partnering-300x150-orphanjpg